Wen‐Bin Ou

4.2k total citations · 2 hit papers
64 papers, 2.9k citations indexed

About

Wen‐Bin Ou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Wen‐Bin Ou has authored 64 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 14 papers in Gastroenterology. Recurrent topics in Wen‐Bin Ou's work include Gastrointestinal Tumor Research and Treatment (14 papers), Sarcoma Diagnosis and Treatment (10 papers) and Muscle metabolism and nutrition (6 papers). Wen‐Bin Ou is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (14 papers), Sarcoma Diagnosis and Treatment (10 papers) and Muscle metabolism and nutrition (6 papers). Wen‐Bin Ou collaborates with scholars based in China, United States and Canada. Wen‐Bin Ou's co-authors include Jonathan A. Fletcher, Christopher L. Corless, Michael C. Heinrich, George D. Demetri, Christopher D.�M. Fletcher, Adrián Mariño‐Enríquez, Hai‐Meng Zhou, Yong‐Doo Park, Charles D. Blanke and Burton Eisenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Wen‐Bin Ou

63 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

2006 609 citations Michael C. Heinrich, Christopher L. Corless et al. Journal of Clinical Oncology profile →
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

2008 564 citations Michael C. Heinrich, Robert G. Maki et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen‐Bin Ou China	27	1.4k	1.1k	862	491	427	64	2.9k
Chenghong Peng China	41	1.1k 0.8×	156 0.1×	2.0k 2.3×	1.8k 3.6×	2.1k 5.0×	200	5.1k
Takaya Shimura Japan	25	648 0.5×	188 0.2×	465 0.5×	517 1.1×	624 1.5×	145	1.8k
Éric Guérin France	27	503 0.4×	90 0.1×	811 0.9×	158 0.3×	693 1.6×	75	1.7k
Xiaoling Du China	24	461 0.3×	56 0.0×	605 0.7×	76 0.2×	339 0.8×	53	1.3k
Hong‐Tao Xu China	26	336 0.2×	38 0.0×	1.2k 1.4×	187 0.4×	384 0.9×	125	1.9k
Shi Yang United States	31	876 0.6×	39 0.0×	1.1k 1.3×	412 0.8×	1.9k 4.4×	105	3.8k
Jun Ho Yi South Korea	22	214 0.1×	62 0.1×	514 0.6×	163 0.3×	552 1.3×	88	1.5k
Qiong Wu China	28	454 0.3×	31 0.0×	1.1k 1.3×	222 0.5×	833 2.0×	97	2.3k
Olga Martinho Portugal	26	197 0.1×	75 0.1×	967 1.1×	98 0.2×	308 0.7×	58	1.7k
Katsuyuki Kusuzaki Japan	31	1.3k 0.9×	16 0.0×	891 1.0×	368 0.7×	605 1.4×	142	2.9k

Countries citing papers authored by Wen‐Bin Ou

Since Specialization

Citations

This map shows the geographic impact of Wen‐Bin Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Bin Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Bin Ou more than expected).

Fields of papers citing papers by Wen‐Bin Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Bin Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Bin Ou. The network helps show where Wen‐Bin Ou may publish in the future.

Co-authorship network of co-authors of Wen‐Bin Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Bin Ou. A scholar is included among the top collaborators of Wen‐Bin Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Bin Ou. Wen‐Bin Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hailong, Hao Wang, Zong Li, et al.. (2025). Anti-proliferative and anti-invasive effects of exogenous thermostable MnSOD in gastric cancer associated with p53 and ZEB1 expression. Journal of Cancer. 16(6). 2062–2074. 1 indexed citations

Ding, An, et al.. (2025). SMARCA4: Promises and challenges in the treatment of cancers. Cancer Letters. 625. 217811–217811. 1 indexed citations

Qiao, Yue, et al.. (2024). Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(3). 189108–189108. 8 indexed citations

Xu, Liangliang, Weili Yang, César Serrano, et al.. (2023). Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166690–166690. 7 indexed citations

Chen, Xiang, Pei‐Pei Yang, Fei Ye, et al.. (2022). Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2. Scientific Reports. 12(1). 18830–18830. 6 indexed citations

Liu, Xin, Jiale Chen, Wenyu Yang, et al.. (2021). Biosynthesis of silver nanoparticles with antimicrobial and anticancer properties using two novel yeasts. Scientific Reports. 11(1). 15795–15795. 34 indexed citations

Ou, Wen‐Bin, Nan Ni, Rui Zuo, et al.. (2019). Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence. Oncogene. 38(39). 6615–6629. 24 indexed citations

Huang, Mengyuan, Wenyu Yang, Jiaqing Zhu, et al.. (2019). Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours. British Journal of Cancer. 122(3). 372–381. 4 indexed citations

He, Quan, et al.. (2018). Comparative study on the composition of free amino acids and derivatives in the two botanical origins of an edible Chinese herb “Xiebai”, i.e., Allium chinense G. Don and Allium macrostemon Bunge species. Food Research International. 106. 446–457. 31 indexed citations

10.

Li, Ouyang, Quan He, Mengyi Zhu, et al.. (2018). Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection. Stem Cell Research & Therapy. 9(1). 49–49. 25 indexed citations

11.

Chen, Weicai, Ye Kuang, Haibo Qiu, et al.. (2017). Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Research. 77(18). 5107–5117. 28 indexed citations

12.

Lee, Jen‐Chieh, Chien‐Feng Li, Hsuan-Ying Huang, et al.. (2016). ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1‐ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. The Journal of Pathology. 241(3). 316–323. 95 indexed citations

13.

Wu, Yuehong, Jianhong Shu, Min Li, et al.. (2015). ROCK inhibitor Y27632 promotes proliferation and diminishes apoptosis of marmoset induced pluripotent stem cells by suppressing expression and activity of caspase 3. Theriogenology. 85(2). 302–314. 31 indexed citations

14.

Li, Xuhui, Xiangjun Chen, Wen‐Bin Ou, et al.. (2013). Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis. The International Journal of Biochemistry & Cell Biology. 45(5). 979–986. 52 indexed citations

15.

Parkkila, Seppo, Jerzy Lasota, Jonathan A. Fletcher, et al.. (2010). Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Modern Pathology. 23(5). 743–750. 78 indexed citations

16.

Heinrich, Michael C., Robert G. Maki, Christopher L. Corless, et al.. (2008). Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 26(33). 5352–5359. 564 indexed citations breakdown →

17.

Ou, Wen‐Bin, et al.. (2003). Effects of lactic acid and NaCl on creatine kinase from rabbit muscle. Biochemistry and Cell Biology. 81(1). 1–7. 15 indexed citations

18.

Ou, Wen‐Bin, et al.. (2003). Effects of arginine on rabbit muscle creatine kinase and salt-induced molten globule-like state. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1652(1). 7–16. 3 indexed citations

19.

Ou, Wen‐Bin, et al.. (2002). Conformational changes and inactivation of rabbit muscle creatine kinase in dimethyl sulfoxide solutions. Biochemistry and Cell Biology. 80(4). 427–434. 6 indexed citations

20.

Ou, Wen‐Bin, Yong‐Doo Park, & Hai‐Meng Zhou. (2001). Molecular mechanism for osmolyte protection of creatine kinase against guanidine denaturation. European Journal of Biochemistry. 268(22). 5901–5911. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact